Partial resolution of acute ascending motor polyneuropathy after enucleation of an eye with metastatic melanoma Malignant melanoma is an immunological tumour, and the glycoproteins on the surface of melanoma cells share immunogenic similarity with cells in the central and peripheral nervous system. Several clinical signs have been suggested to result from this similarity including vitiligo, syndrome of inappropriate antidiuretic hormone secretion (SIADH), and chronic inflammatory demyelinating polyneuropathy. 1 2 We describe a patient with metastatic melanoma in the eye, who developed uveitis associated with ascending motor neuropathy. Enucleation of her blind painful eye resulted in marked improvement in her neurological abnormalities.
Case report
A 21 year old woman with a history of stage III cutaneous melanoma presented with anterior uveitis in her left eye. Visual acuity, intraocular pressure, and posterior pole examinations were within normal limits. Right eye examination was unremarkable. A diagnostic anterior chamber tap, left eye, revealed melanoma tumour cells.
One month later she developed a profound ascending motor polyneuropathy compatible with the diagnosis of Guillain-Barré syndrome. Clinical examination showed weakness of her upper and lower extremities, and decreased reflexes with no signs of sensory neuropathy. Lumbar puncture demonstrated 3 white blood cells 610 6 /l. Magnetic resonance imaging of her thorax, cervical and lumbar spine showed no evidence of spinal cord or leptomeningeal disease.
The neurological symptoms worsened proportionally to the disease progression in her eye, and the level of neuron specific enolase (NSE) rose from a low value of 16 to a high value of 36 ng/ml. She was treated with several courses of high dose intravenous gamma globulin (IVIG) with slight but temporary improvement.
Six weeks after initial presentation, because of severe refractory disease in the left eye (fig 1) , she underwent a left eye enucleation. Histopathological examination showed malignant melanoma involving the ciliary body, iris, trabecular meshwork, and vitreous cavity ( fig 2) . Since the enucleation her polyneuropathy has markedly improved. NSE decreased to 12 ng/ml (normal 0-10). She has continued to receive IVIG and autologus dendritic cell vaccine and, 18 weeks after enucleation, showed partial (.50%) resolution of the polyneuropathy with substantial but as yet incomplete recovery of lower and upper extremity weakness.
Comment
The patient presented with uveitis and metastatic melanoma in her left eye. She developed a severe ascending motor polyneuropathy compatible with the diagnosis of Guillain-Barré syndrome. Enucleation of the blind, painful left eye resulted in substantial clinical and laboratory improvement in the polyneuropathy.
Ascending motor polyneuropathy in our patient may have been caused by an immune reaction directed to antigens in the tumour that cross reacted in the nervous system. Marked improvement in her overall peripheral muscle strength after the enucleation suggests a relation between the progressive dysimmune polyneuropathy and the intraocular involvement. More evidence of a tumour related immune response was shown by post-enucleation decrease in the level of NSE, a specific marker for metastatic disease in melanoma where its increase points to disease progression. 3 Various paraneoplastic neuropathies have been described in association with cancer, including subacute sensory neuropathy/ paraneoplastic encephalomyelitis, 4 Guillain-Barré syndrome, and axonal polyneuropathy; 5 and specifically in melanoma: chronic inflammatory demyelinating polyneuropathy, 1 ophthalmoplegia, and subacute motor axonal neuropathy. 2 The relation between enucleation and improvement of the neuropathy is not clear; improvement may have been a spontaneous remission. However, the appearance of neuropathy soon after the onset of uveitis and the partial (.50%) resolution after enucleation raise the possibility that molecular mimicry and antigenic cross reaction were the cause of the polyneuropathy. Enucleation, by reducing the cross reacting antigens, is likely to have contributed to resolution of the polyneuropathy. 
Aspergillus keratitis following corneal foreign body
Recognition, diagnosis, and management of fungal keratitis remain difficult despite significant advances in our understanding of the disease. [1] [2] [3] [4] We report three cases secondary to corneal foreign body which were managed at Manchester Royal Eye Hospital (MREH)
Case reports

Case 1
A 22 year old man presented to MREH with a metallic corneal foreign body that was removed; chloramphenicol eye drops were prescribed.
He returned 3 days later with pain, hand movement vision, a round corneal ulcer, and a hypopyon. A corneal scrape was performed and he was treated with intensive topical antibiotics. The Gram stain showed few fungal hyphae which were thought to be contaminants. The patient was reviewed by the corneal service 6 days after his injury. As the patient was clinically improving, the antibiotic treatment was continued.
On day 7 a scanty growth of Aspergillus fumigatus was reported. The topical antibiotics were discontinued and he was started on miconazole eye drops 1% hourly.
The ulcer continued to heal slowly and at final review 1 month later vision was 6/9.
Case 2
A metallic corneal foreign body was removed from a 53 year old man; he was treated with chloramphenicol eye drops.
Two days later he developed a corneal ulcer with a hypopyon which was scraped and treated with intensive topical antibiotics. The corneal scrape showed a scanty growth of Aspergillus fumigatus. He was commenced on amphotericin eye drops 0.15% hourly and antibiotics were discontinued.
He was referred to MREH 23 days after his injury with no improvement ( fig 1A) . A second corneal scrape was performed which showed hyphal fragments on the Gram stain. Oral intraconazole 200 mg three times daily was added to treatment.
In view of the deteriorating clinical condition a penetrating keratoplasty was performed and amphotericin (7.5 mg) was given intracamerally. Aspergillus fumigatus was present in the corneal button with a clear edge. Thirty months after surgery his best corrected vision was 6/6.
Case 3
A metallic corneal foreign body was removed in casualty from a 46 year old man; he was treated with chloramphenicol eye drops.
Two days later, he presented with increasing pain, hand movement vision, and a corneal ulcer which was scraped. The Gram stain showed a few inflammatory cells. The patient failed to respond to intensive topical antibiotics.
Aspergillus fumigatus was reported and he was treated with hourly natamycin and clotrimazole eye drops, and oral fluconazole 200 mg twice daily. On day 23 fluconazole was discontinued and itraconazole 200 mg twice daily was commenced.
The patient was referred to MREH corneal service 29 days after his injury with no change in the clinical picture ( fig 1B) . The cornea was rescraped confirming presence of aspergillus infection. Topical treatment was changed to amphotericin eye drops and oral itraconazole was increased to three times daily.
Finally, a penetrating keratoplasty was performed with intracameral amphotericin-B (7.5 mg). Aspergillus fumigatus was present in the corneal button with a clear edge.
Phacoemulsification and lens implantation were carried out 2 months after the graft. Thirty months after keratoplasty the graft remained clear with 6/18 vision.
Comment
Most fungal keratitis is caused by filamentous fungi with the epidemiology varying throughout the world. 1 5-7 It is believed to be rare in Britain especially after injury with a metallic foreign body. Our cases demonstrate the difficulties in establishing a diagnosis by culture. Two patients required a therapeutic keratoplasty, which eliminates 90-100% of fungal infections. 8 In recent reports intracameral amphotericin has been used, 9 as part of the medical treatment which may prove useful if aspergillus keratitis becomes more common in the Britain.
The clinical evolution of a kissing naevus after incomplete excision
We present an interesting case of a kissing naevus which was not completely excised during the patient's childhood, 29 years before presentation.
Case report
A 33 year old white man complained of progressive thickening of the eyelids which caused significant inferior visual field defect with downgaze (fig 1) . A large, circumorbital pigmented naevus in the right eye had been present since birth. There was minimal growth through early childhood. This mass did not cause ptosis nor was it amblyogenic.
At 4K years of age he had excision of the naevus of the right lower eyelid with reconstruction with a split thickness skin graft (fig 2) . Of significance, he had incomplete excision of a kissing naevus from his eyelids as a child. At age 6 a similar procedure was performed to address the upper eyelid and brow. The margin of the upper eyelid also had residual pigmentation.
When he was aged 33, we performed a biopsy to rule out malignant changes; the biopsy confirmed a diagnosis of dermal naevus. Subsequently, a complete excision of the mass from the right lower eyelid and reconstruction with a full thickness skin graft was performed.
Comment
A kissing naevus is a type of congenital compound naevus that affects equal portions of the upper and lower eyelid. Owing to its extension to the lid margins, the edges of the tumour touch or ''kiss'' during closure of the lids. 1 The kissing naevus origin dates to melanocyte migration during the embryological fusion of the lids at the ninth week of gestation, producing the ''kissing'' or split naevus. 2 Congenital naevi occur in approximately 1% of all newborns, with the vast majority being less than 1.5 cm in size. 3 Compound naevi possess features of junctional (arising from the deeper layers of the epidermis or ''junctional region'') and intradermal naevi. The lifetime risk of malignant degeneration in small congenital naevi is not clearly established. Large cutaneous melanocytic naevi (more than 4 cm), however, do give rise to melanoma. 4 The risk of malignant transformation is 4.6% during a 30 year period. 5 Kissing naevi of the eyelids may be cosmetically objectionable and cause functional problems including ptosis and visual field defects. Management usually requires surgical excision and reconstruction with split or full thickness skin grafts. Initial, complete excision is important because residual tumour can grow, often with a more verrucous or thickened appearance making subsequent determination of malignant transformation and reconstruction challenging. 
W Y Wu-Chen, C R Bernardino, P A D Rubin
Comments on confocal microscopy of Aspergillus fumigatus keratitis
We read with great interest the article of Avunduk and coworkers, 1 who conducted a study in using confocal microscopy to evaluate Aspergillus fumigatus keratitis in treated and untreated rabbit eyes. They concluded that ''confocal microscopy is a rapid and sensitive diagnostic tool for both the early diagnosis and non-invasive follow up of fungal keratitis.'' In order to justify the statement, two issues of concern on the early diagnosis have to be addressed. The first is about the sensitivity in having positive diagnosis in the untreated eyes in the first experiment. On day 2, all 14 samples were smear and culture positive for Aspergillus fumigatus, therefore confocal microscopy could not demonstrate any superiority in early diagnosis in terms of sensitivity. On days 14 and 22 their conclusion that ''confocal microscopy was more sensitive than culture technique'' also could not be drawn unless the authors could enlighten us with supplementary data on the percentages of positive culture in those periods together with their p values.
Another issue is about computation of statistical values in the second experiment. The authors implied that topical and orally treated eyes had significantly lower positive culture growth than the control group receiving no treatment on days 14 and 22 by listing p values of 0.002 and 0.003. However, in performing the x 2 analysis again with the data provided, we can only achieve p = 0.391 and p = 0.280 on day 14 and p = 0.308 and p = 0.237 on day 22. We would suggest that statistical differences cannot be demonstrated in these parts of study, at least, with such a sample size. 
D S Fan, D T L Liu, W-M Chan, D S C Lam
Authors' reply
We thank Dr Fan and coworkers for their letter and interest in our article. The conclusion drawn by us was that confocal microscopy was a rapid and sensitive diagnostic tool for both early diagnosis and non-invasive follow up of fungal keratitis, not that it was superior to culture and corneal biopsy staining techniques in the early stage of fungal keratitis. It is rapid compared to culture and biopsy staining techniques, since we were able to detect fungal hyphae in all rabbit eyes 2 days after fungal inoculation, but at least 2-3 days had to elapse to determine any fungal growth on Sabouraud's agar. Moreover, O'Day et al 1 Figure 2 A photomontage of the appearance of the circumorbital naevus throughout childhood.
(1) 6 months of age, (2) 4 years of age, (3) after excision from lower eyelid at age 4K, (4) after excision from upper eyelid at age 6. Note the residual pigmentation of lid margin in (3) and (4). reported that about one fourth of fungal cultures became positive only after 2 weeks. Confocal microscopy is also rapid compared to biopsy staining, since to perform calcofluor staining some time had to elapse. As stated in our article 2 ''Although in our model Sabouraud's agar and corneal biopsy techniques showed similar sensitivity (100%) in the early stage, confocal microscopy appears to have a definitive advantage in the later stages of infection, since not all cases of fungal keratitis could be cultured.'' In the abstract we wrote that ''on days 14 and 22 confocal microscopy was more sensitive than culture technique in both treated and untreated animals, since not all cases of fungal keratitis could be cultured.'' We think the conclusion drawn is valid in light of the data provided in the study. In the second experiment, six rabbits were treated with topical fluconazole, seven were treated with oral fluconazole, and seven were left untreated. On day 14, we observed hyphal fragments (broken in treated corneas and full size in untreated ones) in each of 20 corneas by confocal microscopy. However, only eight of 20 scrapings grew Aspergillus fumigatus on Sabouraud's agar culture. The difference between groups was statistically significant as is given in the text by utilising x 2 test. Similarly, on day 22 confocal microscopy revealed hyphal fragments in 14 corneas out of 20 (three in the topically treated, four in the orally treated, and seven in the untreated groups). At this stage only five corneal scrapings grew fungus on culture. The difference was statistically significant again as given in the article by utilising the x 2 test. Thus, superiority of confocal microscopy over culture technique on days 14 and 22 in treated and untreated rabbits was supported well by the data presented in the article.
MAILBOX
In the result section, we were attempting to determine the efficacies of topical and oral fluconazole treatment by culture. However, p values were not correct as a result of an error. The errors escaped both our and the reviewer's attention. However, this part of the results section does not contain any information that could affect any conclusion drawn as a result of study data. Actually, this part was not directly linked to the main aim of the study. The authors wish to thank to Dr Fan and coworkers for their careful attention.
The correct p values are given here: on day 14 (p = 0.383 and p = 0.296); on day 22 (p = 0.342 and p = 0.279). 
A M Avunduk, R W Beuerman, E D Varnell, H E Kaufman
Macular infarction after intravitreal amikacin
We write in reference to the letter by Galloway et al. 1 The authors report a single case of macular infarction in a patient who had been given intravitreal amikacin for endophthalmitis. They cite that single case plus some previous literature as a reason to support a change in the choice of antibiotic for intravitreal injection from the treatment guidelines based on the results of the Endophthalmitis Vitrectomy Study (EVS).
While aminoglycoside induced retinal toxicity certainly can occur, we disagree with their statement that there is good evidence that aminoglycosides should not be primary drugs of choice in this disease. There are several theoretical and practical advantages of aminoglycosides over ceftazidime. Amikacin provides concentration dependent killing (so that the higher concentration of drug the more rapid the kill) which is not true for ceftazidime. This is an important issue since high concentrations of drug are administered by intravitreal injection, thus possibly allowing for more rapid kill with amikacin.
Amikacin is considered to be synergistic with vancomycin for certain Gram positive species, so its use provides benefit against Gram positive organisms, not just for Gram negative organisms. Gram positive organisms make up the overwhelming majority of cases of endophthalmitis. In addition, there has been a recent report that ceftazidime may precipitate in the vitreous at normal body temperature, 2 possibly making it less available than one might wish in the vitreous cavity.
Finally, and very importantly, is the fact that amikacin has been found to be effective in a clinical trial but there is no such evidence yet available on ceftazidime. The only apparent advantage of ceftazidime is that it may be a somewhat safer drug in the sense that macular toxicity has not been reported. Even so, the incidence of macular toxicity is extremely rare (only one in 420 eyes in the EVS suffered macular toxicity possibly from the drug). In a very severe disease such as endophthalmitis a risk this low is worth tolerating when there may be substantial potential advantages. 
B H Doft
